Everand Logo

Welcome to Everand!

  • STAT

    Controversial contraception app approved in U.S. drawing scrutiny overseas

    A Swedish regulator is set to release the findings of an investigation into a controversial contraception app, Natural Cycles, which was recently approved in the U.S.
    by Kate Sheridan Sep 11, 2018 4 minutes

    European regulators are ramping up their scrutiny of a controversial app that its backers hail as a side-effect-free alternative to hormonal birth control pills — and which the Food and Drug Administration in the U.S. just cleared last month.

    The Swedish Medical Products Agency is set to release the findings of a monthslong investigation into the app, Natural Cycles, as soon as this week. Earlier this year, a spate of women in that country unintended pregnancies after using the app. Separately, the U.K.’s advertising regulator on Aug. 29 that a 2017 Facebook advertisement for Natural Cycles that claimed the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks